Filter
1439
Filtered Results: 1439
Text search:
adverse
drug
event
Featured
Recommendations
182
New Publications
350
Language
Document type
No document type
790
Guidelines
285
Studies & Reports
176
Manuals
94
Strategic & Response Plan
45
Fact sheets
20
Training Material
16
Situation Updates
6
Infographics
3
Brochures
1
App
1
Resource Platforms
1
Online Courses
1
Countries / Regions
India
94
Global
47
Western and Central Europe
40
South Africa
34
Ethiopia
31
Kenya
29
Nigeria
24
Ghana
23
Latin America and the Carribbean
23
Bangladesh
19
Uganda
18
Eastern Europe
18
Nepal
15
Africa
15
Tanzania
15
Namibia
13
Sierra Leone
12
Philippines
12
South–East Asia Region
12
Liberia
11
Myanmar / Burma
11
Zimbabwe
9
Cambodia
9
Zambia
9
Rwanda
8
Malawi
8
Colombia
7
USA
7
Asia
7
Eastern Europe and Central Asia
7
Syria
6
Argentina
6
Brazil
6
Ukraine
5
Mozambique
5
Western Pacific Region
5
East and Southern Africa
5
Botswana
5
Indonesia
5
West and Central Africa
4
Eswatini/ Swaziland
4
Timor Leste/ East Timor
3
Thailand
3
Lesotho
3
Germany
3
Middle East and North Africa
3
South Sudan
3
North Macedonia
2
Tajikistan
2
China
2
Chile
2
Laos
2
Congo, Democratic Republic of
2
Paraguay
2
United Kingdom
2
Bolivia
2
Vietnam
2
Georgia
2
Angola
2
Bhutan
2
North Korea
1
Australia
1
Kazakhstan
1
Cameroon
1
Albania
1
Fiji
1
Senegal
1
Kyrgyzstan
1
Bulgaria
1
Guinea
1
Haiti
1
Guinea-Bissau
1
Ireland
1
North America
1
Belarus
1
Lebanon
1
Sri Lanka
1
Russia
1
Mali
1
Chad
1
Iraq
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
455
Clinical Guidelines
225
Public Health
88
Women & Child Health
73
Key Resources
46
Pharmacy & Technologies
26
Capacity Building
21
Toolboxes
TB
157
Mental Health
144
HIV
136
COVID-19
79
Pharmacy
73
NTDs
60
AMR
57
Rapid Response
37
NCDs
32
Caregiver
31
Malaria
28
Ebola & Marburg
23
Planetary Health
20
Refugee
18
Global Health Education
16
Specific Hazards
14
Conflict
13
Polio
11
Disability
9
Natural Hazards
6
Cholera
6
Zika
5
Health Financing Toolbox
3
Social Ethics
2
Monitoring of implementation of collaborative TB/HIV activities and evaluation of impact is critically important. This requires efficient monitoring and evaluation system so as to establish accountability mechanisms between programmes, the population they serve, and donors. The Guide to monitoring a...
The UNICEF-GAIN Partnership Project
The report notes that iodine deficiency is a leading cause of preventable brain damage worldwide. Insufficient iodine during pregnancy and infancy results in neurological and psychological deficits, reducing a child’s IQ by 8 to 10 points. This translates ...
The report notes that iodine deficiency is a leading cause of preventable brain damage worldwide. Insufficient iodine during pregnancy and infancy results in neurological and psychological deficits, reducing a child’s IQ by 8 to 10 points. This translates ...
Diabetes mellitus is a major cause of morbidity and mortality in Scotland and worldwide, with an increasing prevalence. In 2009 there were around 228,000 people registered as having diabetes in Scotland, an increase of 3.6% from the preceding year. This increase relates, in part, to the increasing a...
Cervical intraepithelial neoplasia (CIN) is a premalignant lesion that may exist at any one of three stages: CIN1, CIN2, or CIN3. If left untreated, CIN2 or CIN3 (collectively referred to as CIN2+) can progress to cervical cancer. Instead of screening and diagnosis by the standard sequence of cytolo...
In this report, we describe early childhood trauma and its effects, offer promising strategies for ECE programs and systems to help young children who have experienced trauma, and present recommendations for state policymakers and other stakeholders looking to support trauma-informed ECE for this vu...
A key purpose of the Recovery Toolkit is to support countries in the reactivation of health services which may have suffered as a result of the emergency. These services include ongoing programmes such as immunization and vaccinations, maternal and child health services, and noncommunicable diseases...
A Provisional Document. The purpose of this manual is to provide guidance to public health professionals tasked with managing a response to viral hepatitis. As every country’s needs are different with respect to its epidemiology and the current level of response, people would use this manual in di...
WHO clinical and policy guidelines
The aim of this document is to provide interim guidance for interventions to reduce the risk of maternal Zika virus infection and to manage potential complications during pregnancy. This guidance is based on the best available research evidence and covers areas prioritized by an international, multi...
A handbook for leaders and managers
Infection Prevention and Control Programmes
January 2020
Module 10
Testing providers
July 2017
Module 10: Testing providers. This module is for people who provide testing services at PrEP sites and laboratories. It offers guidance in selecting testing services, including screening of individuals before PrEP is initiated and monitoring while they ar...
Mental health conditions affect one in 10 people at any one time and account for a large proportion of non-fatal disease burden. There is a high degree of comorbidity between mental health conditions such as depression and other noncommunicable diseases (NCDs), including cardiovascular disease, diab...
A planner’s guide to proposal development for national school-based deworming programs
This twelfth version of the WHO living guideline now contains 19 recommendations. This latest update provides updated recommendations for remdesivir, addresses the use of combination therapy with corticosteroids, interleukin-6 (IL-6) receptor blockers and Janus kinase (JAK) inhibitors in patients wi...
